Nicholas Erho
7Patents
2h-index
13Co-inventors
44Inventor score
Filing activity: Dec 13, 2012 → Nov 10, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10513737B2 | Cancer diagnostics using non-coding transcripts | Emerging Cross-Sectional Technologies | 6 | Active |
| US11035005B2 | Cancer diagnostics using biomarkers | Chemistry; Metallurgy | 2 | Active |
| US11078542B2 | Genetic signatures to predict prostate cancer metastasis and identify tumor aggressiveness | Physics | 2 | Active |
| US11208697B2 | Molecular subtyping, prognosis, and treatment of bladder cancer | Chemistry; Metallurgy | 1 | Active |
| US12378610B2 | Systems and methods for preprocessing target data and generating predictions using a machine learning model | Chemistry; Metallurgy | 0 | Active |
| US11414708B2 | Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy | Emerging Cross-Sectional Technologies | 0 | Active |
| US11873532B2 | Subtyping prostate cancer to predict response to hormone therapy | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.